20 June 2012
Three papers on vitamin D and MS appear in Neurology. A Norwegian study found that increases in vitamin D level was associated with a reduction in the likelihood of new lesions on MRI, though the effect was not apparent after starting beta interferon. An Australian study found a similar increase in vitamin D reduced the relapse rate by 10%, but only in people on beta interferon. A Dutch study found doubling vitamin D levels reduced risk of relapse by 27%.
Items in Research News link to recent stories that may be of interest to people in the UK.
The MS Trust has not written the original items.
Click on the link beneath the item to be taken to the original story.